Mechanisms of M2 Macrophage-Derived Exosomal Long Non-coding RNA PVT1 in Regulating Th17 Cell Response in Experimental Autoimmune Encephalomyelitisa

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2020 Oct 5

PMID 33013847

Citations 23

Authors

Lei Wu

Jinjin Xia

Donghui Li

Ying Kang

Wei Fang

Peng Huang

Affiliations

Soon will be listed here.

Abstract

Long non-coding RNA (lncRNA) is pivotal for multiple sclerosis (MS), but the potential mechanism of lncRNA PVT1 in MS animal model, experimental autoimmune encephalomyelitis (EAE) still remains unclear. In this study, macrophages were firstly isolated and induced to polarize into M2 macrophages. M2 macrophage-derived exosomes (M2-exos) were extracted and identified, and EAE mouse model was established and treated with M2-exos. The effect of M2-exos on EAE mice was evaluated by clinical scores. The proportion of Treg and Th17 cells in spinal cord cells and splenocytes, and levels of inflammatory factors were measured. The targeting relationships among PVT1, miR-21-5p, and SOCS5 were verified. The expression of JAKs/STAT3 pathway-related proteins was measured. After M2-exo treatment, the clinical score of EAE mice decreased, and demyelination and inflammatory infiltration improved; Th17 cells decreased, Treg cells increased, and the levels of inflammatory factors decreased significantly. SOCS5 and PVT1 were downregulated and miR-21-5p was upregulated in EAE mice. PVT1 could sponge miR-21-5p to regulate SOCS5. SOCS5 alleviated EAE symptoms by repressing the JAKs/STAT3 pathway. Together, M2-exos-carried lncRNA PVT1 sponged miR-21-5p to upregulate SOCS5 and inactivate the JAKs/STAT3 pathway, thus reducing inflammation and protecting EAE mice. This study may offer novel treatments for MS.

Citing Articles

Possible Roles of Extracellular Vesicles in the Pathogenesis and Interventions of Immune-Mediated Central Demyelinating Diseases.

Teekaput C, Thiankhaw K, Chattipakorn N, Chattipakorn S Exp Neurobiol. 2024; 33(2):47-67.

PMID: 38724476 PMC: 11089403. DOI: 10.5607/en24002.

Innovative Diagnosis and Therapeutic Modalities: Engineered Exosomes in Autoimmune Disease.

Ji Y, Mi L, Zhao M, He X, Hu Y, Gao Y Int J Nanomedicine. 2024; 19:3943-3956.

PMID: 38708179 PMC: 11070165. DOI: 10.2147/IJN.S452184.

SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis.

Pandey R, Bakay M, Hakonarson H Front Immunol. 2023; 14:1271102.

PMID: 38022642 PMC: 10643230. DOI: 10.3389/fimmu.2023.1271102.

Long Non-Coding RNA AL928768.3 Promotes Rheumatoid Arthritis Fibroblast-Like Synoviocytes Proliferation, Invasion and Inflammation, While Inhibits Apoptosis Via Activating Lymphotoxin Beta Mediated NF-κB Signaling Pathway.

Sun L, Hu L, Chen P, Li Y, Tu J, Chen J Inflammation. 2023; 47(2):543-556.

PMID: 37919527 DOI: 10.1007/s10753-023-01927-x.

Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances.

Zhang E, Phan P, Zhao Z Acta Pharm Sin B. 2023; 13(5):1789-1827.

PMID: 37250173 PMC: 10213819. DOI: 10.1016/j.apsb.2022.08.020.

References

Naegele M, Martin R . The good and the bad of neuroinflammation in multiple sclerosis. Handb Clin Neurol. 2014; 122:59-87. DOI: 10.1016/B978-0-444-52001-2.00003-0. View

Mikita J, Dubourdieu-Cassagno N, Deloire M, Vekris A, Biran M, Raffard G . Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler. 2010; 17(1):2-15. DOI: 10.1177/1352458510379243. View

Yin Z, Ma T, Huang B, Lin L, Zhou Y, Yan J . Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway. J Exp Clin Cancer Res. 2019; 38(1):310. PMC: 6631643. DOI: 10.1186/s13046-019-1313-x. View

Murugaiyan G, da Cunha A, Ajay A, Joller N, Garo L, Kumaradevan S . MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. J Clin Invest. 2015; 125(3):1069-80. PMC: 4362225. DOI: 10.1172/JCI74347. View

York N, Mendoza J, Ortega S, Benagh A, Tyler A, Firan M . Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis. J Autoimmun. 2010; 35(1):33-44. PMC: 2878858. DOI: 10.1016/j.jaut.2010.01.003. View

Shin T, Ahn M, Matsumoto Y . Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights from macrophages. Anat Cell Biol. 2012; 45(3):141-8. PMC: 3472139. DOI: 10.5115/acb.2012.45.3.141. View

Toghi M, Taheri M, Arsang-Jang S, Ohadi M, Mirfakhraie R, Mazdeh M . SOCS gene family expression profile in the blood of multiple sclerosis patients. J Neurol Sci. 2017; 375:481-485. DOI: 10.1016/j.jns.2017.02.015. View

Zheng X, Hu H, Li S . High expression of lncRNA PVT1 promotes invasion by inducing epithelial-to-mesenchymal transition in esophageal cancer. Oncol Lett. 2016; 12(4):2357-2362. PMC: 5038502. DOI: 10.3892/ol.2016.5026. View

Ma H, Ziegler J, Li C, Sepulveda A, Bedeir A, Grandis J . Sequential activation of inflammatory signaling pathways during graft-versus-host disease (GVHD): early role for STAT1 and STAT3. Cell Immunol. 2011; 268(1):37-46. PMC: 3061826. DOI: 10.1016/j.cellimm.2011.01.008. View

10.

Zhang H, Podojil J, Chang J, Luo X, Miller S . TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. J Immunol. 2010; 184(12):6629-36. PMC: 2882517. DOI: 10.4049/jimmunol.0904044. View

11.

Montero E, Nussbaum G, Kaye J, Perez R, Lage A, Ben-Nun A . Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. J Autoimmun. 2004; 23(1):1-7. DOI: 10.1016/j.jaut.2004.05.001. View

12.

Qiao M, Thornton A, Shevach E . CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive. Immunology. 2007; 120(4):447-55. PMC: 2265911. DOI: 10.1111/j.1365-2567.2007.02544.x. View

13.

Fletcher J, Lalor S, Sweeney C, Tubridy N, Mills K . T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2010; 162(1):1-11. PMC: 2990924. DOI: 10.1111/j.1365-2249.2010.04143.x. View

14.

Wagner C, Goverman J . Novel Insights and Therapeutics in Multiple Sclerosis. F1000Res. 2015; 4(F1000 Faculty Rev):517. PMC: 4544373. DOI: 10.12688/f1000research.6378.1. View

15.

Colombo T, Farina L, Macino G, Paci P . PVT1: a rising star among oncogenic long noncoding RNAs. Biomed Res Int. 2015; 2015:304208. PMC: 4391155. DOI: 10.1155/2015/304208. View

16.

Sporici R, Issekutz T . CXCR3 blockade inhibits T-cell migration into the CNS during EAE and prevents development of adoptively transferred, but not actively induced, disease. Eur J Immunol. 2010; 40(10):2751-61. DOI: 10.1002/eji.200939975. View

17.

Wang H, Fan H, Tao J, Shao Q, Ding Q . MicroRNA-21 silencing prolongs islet allograft survival by inhibiting Th17 cells. Int Immunopharmacol. 2018; 66:274-281. DOI: 10.1016/j.intimp.2018.11.022. View

18.

Agalave N, Lane B, Mody P, Szabo-Pardi T, Burton M . Isolation, culture, and downstream characterization of primary microglia and astrocytes from adult rodent brain and spinal cord. J Neurosci Methods. 2020; 340:108742. PMC: 7293863. DOI: 10.1016/j.jneumeth.2020.108742. View

19.

Fenoglio C, Cantoni C, De Riz M, Ridolfi E, Cortini F, Serpente M . Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis. Neurosci Lett. 2011; 504(1):9-12. DOI: 10.1016/j.neulet.2011.08.021. View

20.

Robinson A, Harp C, Noronha A, Miller S . The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol. 2014; 122:173-89. PMC: 3981554. DOI: 10.1016/B978-0-444-52001-2.00008-X. View